REGISTERED
on 17 Dec 2024
Last Applicant/ Owned by
151 Oyster Point Boulevard, 2nd Floor
South San Francisco
CA
94080
Serial Number
90981081 filed on 27th May 2021
Registration Number
7614242 registered on 17th Dec 2024
Correspondent Address
Muzamil Huq
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
F M
Pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer Small molecule pharmaceuticals for the treatment of cancer
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer
First Use Date in General
18th Jul 2021
First Use Date in Commerce
18th Jul 2021
Class [005]
Pharmaceutical Products
Small molecule pharmaceuticals for the treatment of cancer
First Use Date in General
20th Nov 2023
First Use Date in Commerce
20th Nov 2023
Mark Details
Serial Number
No 90981081
Mark Type
No Service Mark
Attorney Docket Number
No 792456006000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.05.03 -
Incomplete triangles (must have two angles)
26.05.21 -
Triangles that are completely or partially shaded
26.13.21 -
Quadrilaterals that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Dec 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 17th Dec 2024 | REGISTERED-PRINCIPAL REGISTER |
| 22nd Aug 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 21st Aug 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 21st Aug 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 27th Jul 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 27th Jul 2024 | DIVISIONAL PROCESSING COMPLETE |
| 24th Jun 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th May 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| 17th May 2024 | USE AMENDMENT FILED |